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Chapter 7
Quantitative model of glucose transfer in subcutaneous
interstitial gradients assessed with oral glucose tolerance




Introduction: The aim of this study was to test compartmental models for
subcutaneous glucose kinetics in order to find which determinants contribute,
and to what extent to subcutaneous glucose levels. A secondary aim was to
evaluate the possibility to reverse the algorithm found.
Methods: The data of the seven subjects in chapter 6 were used to evaluate
three models. Model A is a two compartments model, using the measured
arterial glucose as the linear input into the connective tissue compartment. The
latter compartment has one linear glucose output. Model B is like A, but
modifies the output using the arterial insulin levels. Model C is like B, but adds
a third compartment between the arterial and the connective tissue
compartment, and modifies also the input using the arterial insulin levels. To
identify the best model, first the model parameters have been estimated by
weighted nonlinear least squares. Second, to make a comparison among the
models in terms of parsimony, the Akaike Information Criterion was used.
Results: The parameter precision was acceptable (coefficient of variation below
100%) and the fractional standard deviation was estimated to be below 5%.
Model B showed the best fit, with model C in second place. However, the
results also show parameters k3 and k4 (insulin effect) to virtually disappear in
some subjects, suggesting a more simple model is then sufficient.
Conclusions: The heterogeneity of the parameters found may be a reflection of
the mix in the subcutis of insulin dependent adipose and insulin independent
connective tissue, and the tissue concentrations varying with the distance to the
nearest capillaries.
A future reversement of the best model found will need the insulin levels as
input for the algorithm. This will be possible, as the previous insulin
administration will be remembered by a future artificial pancreas. However, the
presented model needs additional data in future studies to be validated for this
purpose.
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Introduction
The fate of glucose in the interstitial fluid of tissues is of importance to better
understand some pathophysiologic mechanisms in diabetes mellitus.
Accordingly, interstitial fluid may inform more specific on tissue metabolism
than blood, because the interstitium is usually regarded as one or more
kinetically separate compartments and the place of action of insulin(1). Major
pathophysiologic phenomena localised in tissue are insulin resistance(2) and
increased capillary permeability related to diabetic and hypertensive
complications(3). Further, the proper functioning of pancreatic islets transplants
appears to depend not only on controlling the immunologic rejection, but also
on creating a close kinetic contact with the bloodstream(4). An interstitial
glucose kinetic model may help to understand the basics of metabolism inside
tissue in control conditions and of diabetic pathophysiology. Such model may
also improve the interpretation of interstitial glucose sensor measurements,
intended to manage diabetes without blood sampling(5-7).
Glucose kinetic models have been developed previously for the entire body, e.g.
the so-called “minimal model”(1). The interstitial fluid proper can be modelled
thus far only indirectly by the input-output method (arterial-venous differences
measurement)(8), by the glucose clamp method, or by thoracic duct lymph
measurements(9). All these attempts to validate the characteristics of peripheral
interstitial fluid compartment in a glucose kinetics model were inevitably
indirect, because of hitherto technical inaccessibility of the human interstitial
compartment. Thoracic duct lymph is mostly constituted by liver and intestines,
which glucose metabolism differs considerably from peripheral tissues as
muscle, fat, and connective tissue. So, the important insulin effect on the
peripheral tissues can be modelled little with thoracic duct lymph
measurements. There is also criticism on compartmental modelling concerning
the assumptions of no concentration gradients within compartments, and only
single transfer rates between compartments(10).
Application of microdialysis probes placed directly in the subcutaneous
interstitium for continuous sampling or implantation of glucose sensors has
made local on-line measurements in principle possible. However, in current
studies using classical microdialysis, sample collection time is 10 to 60 minutes,
and the probe creates a concentration gradient in the surrounding tissue.
Calibration needed in vivo to correct for microdialysis tissue drainage is a rather
complicated and time-consuming procedure, and requires often additional blood
sampling. Directly implanted amperometric glucose sensors need in vivo
calibration as well. Because any physiologic glucose gradients between
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subcutaneous and blood levels are thus also calibrated for, no uptake in tissue
can be found, but only a rate constant for delay(7).
Recently, an ultraslow microdialysis method has been developed, which
recovers completely equilibrated samples(11). With such a continuous sampling
method, glucose measurements can be done every minute using a biosensor in a
coupled flow-injection analysis system(12). So, very frequent direct
measurements of absolute glucose concentrations have now become possible in
the subcutaneous compartment without additional assumptions or computations.
This approach allows to investigate kinetics of glucose in the subcutaneous
compartment of individual subjects. In preclinical experiments in healthy
volunteers to validate this method, both delays and lower glucose levels were
observed in the subcutis as compared to venous blood plasma. In order to make
subcutaneous sensors accurate and reliable, this difference has to be explained
and, if possible, avoided or predicted. A subcutaneous kinetic model may enable
to predict blood levels from subcutaneous glucose with an appropriate
algorithm(7), provided the model allows inversion.
Here, we analysed glucose and insulin data from Oral Glucose Tolerance Tests
(OGTTs) in seven healthy volunteers. The data were described by three models
with rising complexity to select the best quantitative model to predict
subcutaneous glucose levels from arteriolized blood plasma measurements,
which were used as the input function for the models. We chose a new approach
by comparing lumped parameters between the compartments with multiple
parameters, taking into account the characteristics of two different glucose
transporters: GLUT1 and GLUT4. GLUT1 plays a role in constitutive glucose
uptake over the cell membrane, whereas GLUT4 can be moved by insulin from
specific membrane vesicles inside the cell to its surface. Further, we
individualised the parameters for each experiment, so taking into account the
possibility of concentration gradients in the studied compartments. The glucose
levels in the blood plasma and subcutaneous compartment were assumed to
represent a homeostatic steady state immediately before the experiment. Three
models were studied. In the simplest model (model A), transport from blood
plasma to the interstitium (by blood filtration (solvent drag) and diffusion) was
described by one linear rate. The transport from the interstitium to the blood
plasma and/or into cells (by diffusion, reabsorption, and physiological glucose
uptake (glucose dependent below a level of ±10 mM) was described by a
second linear rate. In the model B, the second linear rate was the sum of two
rates, one of these two being linearly proportionate to the blood insulin level
above steady state level (insulin dependent glucose uptake). Model C is like
model B with addition of an insulin dependent glucose transport from blood
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plasma to the interstitium (insulin dependent glucose distribution), and with a
third compartment between blood plasma and interstitium , representing the
capillary blood filtration. The closest and simplest quantitative description of
the set of measurements is selected as the best model.
The main question of the present study is, to what extent tissue metabolism
events are isolated from blood plasma in terms of number and influence of
model parameters. Relevant is especially whether insulin is of importance in
explaining the observed gradient and delay in glucose transfer glucose between
the compartments. Insulin constitutes namely a from glucose independent factor
in diabetic patients. So insulin is potentially an uncontrollable interferent in
subcutaneous glucose measurements, and thus difficult to use in an inverse
model for a sensor algorithm. In the discussion we will discuss the plausibility




A 100g oral glucose tolerance test was performed on the day after probe
placement in seven healthy women between 23 and 45 years old, without
(family) history of diabetes. Measurements included weight, height, waist
circumference (at the point of minimal abdominal girth), and skinfold thickness
at the probe site. The CMA 60 microdialysis probe was inserted with an
introducer (l=54mm, o.d.=1.4mm) through a lifted skinfold in the direction of
the umbilicus at 15 cm from the midline. The probe was placed in the loose
connective tissue layer in-between the subcutaneous adipose tissue and the
muscle aponeurosis. Low probe perfusion rates (range 30-59 nl/min) were
applied by a stable suction pump, resulting in equilibrated concentrations of
glucose in the microdialysis perfusate and the subcutaneous space. The average
10-90% response time of the probe to sudden changes of standard
concentrations post-vivo was 4.2 minutes (time for the signal to change from 10
to 90% in a sigmoidal transition from one concentration level (0%) to another
(100%))(Tiessen, submitted). Concurrent with the subcutaneous measurements
were blood samples taken from a cubital vein  catheter every 5 to 15 minutes
during the OGTT and the preceding steady state. Cubital venous blood was
arteriolized by keeping the hand on a warming pad under a cloth. 100 g glucose
dissolved in  200 ml water was ingested at zero time. The Medical Ethical
Committee of the University Hospital of Groningen approved the experimental
procedures, which were in accordance with the Declaration of Helsinki.
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The microdialysis perfusate glucose was analyzed every minute in a flow-
injection analysis with a biosensor as described previously(12). Blood glucose
concentrations were measured in plasma with the Vitros 750 analyser (Ortho-
Clinical Diagnostics, Illkirch Cedex, France) after centrifugation of arteriolised
blood. Insulin levels were determined in blood plasma by radio immuno assay
(Pharmacia & Upjohn, Uppsala, Sweden).
Anthropometric data and parameters of model B were analysed using multiple
linear regression, with the model parameters as the dependent variables and




Glucose modelling was done by considering only the glucose measurements,
i.e. plasma glucose as the known input and the subcutaneous interstitial data as
the output of a linear compartment model. The first model, Model A, is shown
in Fig.1 and described the glucose exchange between plasma and interstitial
space by the following differential equation:
      (1)
where Cplasma is the plasma glucose concentration, Csc is the glucose interstitial
concentration and Cscb represents the steady state value of the subcutaneous
glucose. Parameter k21 (min-1) is the rate constant between plasma and
interstitial space, parameter k02 (min-1) is a rate constant describing both the
exchange between interstitial space and plasma and the irreversible loss into the
tissue.
Fig.1 Model A




                                                        Quantitative model of glucose transfer
117
Considering that before the OGTT experiment one has the steady state relation:
 k21Cp - k21Csch = 0       (2)
one can obtain the following steady state relation:
      (3)
where Cp is the plasma glucose value at the basal state. Thus k02 was the only
parameter to identify of Model A.
The second model, Model B, is shown in Fig.2. It assumes as Model A that
glucose distribution is represented by two compartments. Glucose
disappearance from the interstitial space is now linearly dependent on plasma
insulin concentration above the basic level Ib. In particular the Model B is
described by the following differential equation:
         )      (4)
where Csc and Cplasma have the same meaning above, and I and Ib represent
insulin concentration and the steady state value of the plasma insulin
respectively. Considering that before the OGTT experiment one has the steady
state relation:
      (5)



























The third model, Model C, considers the presence of a delay between plasma
glucose and interstitial glucose and of two nonlinear parameters, i.e. k21(t) and
k02(t), controlled directly by the arterial plasma insulin kinetics. By introducing
a third compartment, we obtained the model in Fig.3 where Cplasma is the plasma
glucose concentration, Cr is the delayed plasma glucose concentration and Csc is
the glucose interstitial concentration. The differential equations describing the
model are:
      (6)
where Cscb and Crb are the steady state values of plasma glucose and delayed
plasma glucose respectively. By considering that before the OGTT experiment
one has the steady state relation:
      (7)
one has:
      (8)
Fig.3 Model C
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Model Identification
Model parameters have been estimated by weighted nonlinear least squares.
Note that there is no equation for the first compartment for both the models,
because Cplasma(t) is assumed to be known and used as the input for model
identification. The interstitial glucose data are described by:
j=1, 2 ... N   (9)
where e(tj) is the measurement error at time tj and N the number of data.
Measurement error was assumed to be additive, uncorrelated, gaussian, zero
mean and with a constant fractional standard deviation (FSD=10% of the
measurement) with an unknown proportionality factor γ:
    (10)
The scale factor γ was estimated a posteriori as:
    (11)
where                   is the value of the cost function evaluated at the minimum, i.e.
for p equal to the vector of estimated model parameters      :
    (12)
Note that γ≈1 would indicate that the assumption FSD=10% is reasonable.
The precision of parameter estimates was expressed as FSD% and obtained
from the inverse of the Fisher information matrix M by:
              COV     =  γ M-1     (13)
To make a comparison among the models in terms of parsimony, the Akaike
Information Criterion (AIC) was used:
                AIC = N ln WRSS      + 2P     (14)
where               is the weighted residual sum of squares, P is the number of
parameters and N is the number of the data points.
ˆ           (p)
   )t(e)t(C)t(C jjscj
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By using Model A, results have been obtained in all the 7 subjects. Parameter
values and their CV are shown in Table 1. CV are acceptable (i.e. <100%) in all
the identified subjects. Note that the mean γ value often is different from 1,
consequently the fractional standard deviation, FSD, of the measurement error
has to be considered less than 5% instead of our original assumption FSD=10%.






a 0.13 (9) 0.12 (9) 0.79 0.39
b 0.07 (5) 0.06 (5) 1.30 0.76
c 1.51 (57) 1.54 (57) 1.27 0.39
d 0.88 (75) 0.92 (75) 0.88 0.82
e 0.09 (17) 0.09 (17) 1.94 4.83
f 0.10 (6) 0.10 (6) 0.40 0.29
g 0.15 (5) 0.15 (5) 0.24 0.27
mean 0.42 0.43 0.98 1.11
SE 0.21 0.22
The results obtained in all the original 7 by using Model B are shown in Table
2. It was not possible to estimate the parameter related with the insulin
stimulation for the remaining 2 subjects, because k3 was estimated equal to
zero. Parameter values and their CV are shown below. CV are acceptable (i.e.








a 0.15 (7) 0.13 (7) 0.00014 (11) 0.42 0.20
b 0.07 (5) 0.06 (5) 0.00004 (20) 1.26 0.74
c 1.44 (54) 1.48 (54) 0* - 1.27 0.39
d 0.71 (71) 0.74 (71) 0.00009 (188) 0.87 0.82
e 0.08 (16) 0.07 (16) 0* - 1.94 4.67
f 0.11 (6) 0.11 (6) 0.00002 (87) 0.36 0.28
g 0.15 (5) 0.15 (5) 0.00003 (35) 0.22 0.26
mean 0.39 0.39 0.00006 0.90 1.05
SE 0.20 0.20 0.00002
* parameter estimate close to zero value
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<100%) in all the identified subjects except for the k3 of the subject ‘d’. FSD
was estimated a posteriori to be less than 5% instead of the assumed FSD=10%.
The model fit to the interstitial data resulted better than the previous ones
obtained by using the Model A.
Model C parameter estimates have been obtained in 6 of the original 7 subjects.
Parameter values and their precision are shown in Table 3. Parameter precision
are acceptable (i.e. CV<100%) in all the identified subjects with the only
exception for the k4 estimate of subject ‘e’. FSD was estimated a posteriori to
be less than 5% instead of the assumed FSD=10%.














a 2.65 (10) 0.140 (14) 0.07 (8) 0.06 (8) 0.00008 (8) 0.01489 (26) 0.12 0.12
b 11.31 (3) 0.005 (12) 0.01 (10) 0.01 (10) 0.00006 (4) 0.00090 (5) 0.42 0.13
c 2.35 (80) 2.544 (78) 1.00 (39) 1.02 (39) 0* - 1.49162 (139) 1.23 0.33
d
e 10.29 (2) 0.004 (7) 0.01 (6) 0.01 (6) 0.00006 (4) 0.00123 (4) 0.22 0.11
f 0.60 (31) 0.805 (36) 0.09 (8) 0.10 (8) 0.00003 (49) 0.57049 (121) 0.35 0.27
g 5.26 (6) 0.264 (9) 0.26 (9) 0.26 (9) 0.00008 (25) 0.00092 (50) 0.27 0.29
mean 5.41 0.627 0.24 0.24 0.00006 0.34668 0.45 0.21
SE 1.82 0.402 0.16 0.16 0.00001 0.24695
* parameter estimate close to zero value
Correlation of anthropometric data and the parameters of model B
Regression analyses between the anthropometric data and the parameters of
model B were all negative, but the tests lacked power (P=0.05, α<0.8).
Conclusions
The central goal of the present study was to determine a model closely
describing the subcutaneous measurements as a prediction from blood plasma
glucose levels in healthy volunteers. The successful identification of such a
model, despite considerable variability of glycemia profiles, underlines the
power of the here chosen new approach. The appliance of individualised
parameters may have contributed to the strength of the model in the sense that it
allows for physiological gradients. The use of ultraslow microdialysis to obtain
absolute interstitial glucose concentrations allows modelling of glucose disposal
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inside tissue, which was previously impossible(7;9). Especially interesting is the
first appliance of multiple parameters between compartments, allowing to
model both glucose and insulin dependent glucose disposal. In the current study
no correlations were found between the model parameters and the body
measures, but this may well be a matter of increasing the number of
experiments.
Results have been obtained for all three proposed models. All three models can
be accepted as possible models as the assumptions of CV<100% and FSD10%
are met. The FSD can be estimated a posteriori to be less than 5% in these
models.
Comparing the models in terms of parsimony, the AIC were higher for Model A
fits than for Model B and Model C fits. Model B or Model C provided a slightly
but significantly better fit than the Model A. Considering only Model B and
Model C, the AIC were higher for Model B fits. However the lack of
identifiability associated with the fits were higher for the Model C (one full
non-convergence in a subject plus a parameter close to zero for Model C; only
two parameter close to zero for Model B),the high CV associated with two
parameters of the Model C (i.e. k4 of subjects c and f) and high variability of
the estimates of k4 allow to select the Model B as the best to describe the data.
So, both models (B and C) with an insulin dependent glucose disappearance
from the interstitium are better than the model (A) without insulin effects. The
quantitative effect of the maximum insulin concentration (about 100mU/L) on
total glucose disappearance can be estimated to be maximal ~60% in model C.
This relatively small effect of insulin may be related to the low rate of glucose
uptake in connective tissue as compared with adipose or muscle tissue(13). The
model parameters found here correspond also with the generally accepted
assumption that transmembrane transport is the rate limiting step in the chain to
glucose metabolism.
The largest impact on all models is made by the parameters which are
independent from insulin. Within each experiment, the parameters k21 and k12
are almost the same as a mathematical reflection of the Cplasma to Csc steady-state
ratio being close to one in all the experiments. Between experiments, the
parameters kr, k21, k12 and k4 display a high (co-)variability. This variability
reflects differences in speed at which the subcutaneous interstitium catches up
with glucose level changes in the blood compartment. The explanation of these
differences may be physiological or due to local reaction on the probe
implantation. Both the mass-transfer at the blood-tissue interface, and the tissue-
probe interface are generally assumed to be determined by diffusion(10). The
present data confirm this assumption, with a subdivision in diffusion and
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capillary filtration (fast solvent drag transport by pressure gradient directly over
the capillary wall, as represented in model C by kr). According to Fick’s law on
diffusion, a concentration difference is needed for mass transfer. This implies
that a concentration difference is a conditio sine qua non for glucose transport
from capillaries to the tissue interstitium, but this need not be steep. During a
75g OGTT, the arterial-venous glucose level difference over abdominal wall
tissues increases from 1.4% in steady state(14) to ~0.7mM at 60 minutes(8;15).
Arterial-venous differences are constituted by metabolite exchanges over the
capillary wall. Consequently, the gradients inside the tissue interstitium lining
the capillaries will be of at least the same extent. The observed individual
kinetic parameters appear to fall within the outline of this physiological
gradient, and may be explained accordingly. Using individualised parameters as
performed here, enables the modelling of compartments with gradients. Another
possible explanation of the variability of the k parameters might be the probe
response time. There was however no correlation between k21 in vivo and the
probe response times in vitro (R2=0.17). So, this is not a plausible explanation.
With a recently developed ultrafiltration probe, we have now reduced the
response time further to 1-2 minutes by reducing the internal dead
volume(submitted). Also, the response curve in vitro may be subtracted
mathematically from the in vivo sensor signal, which is possible by means of
deconvolution(16).
Further, it cannot be excluded that the instrumental lag-time (time from actual
change of concentration to 10% signal change) was underestimated in vivo. The
instrumental lag-time can only be checked independently with limited precision
by weighing the nanolitre flow pump on a milligram balance.
The implantation of the probe in the subcutaneous tissue can also not be
excluded as a cause for the observed differences between the arterial and the
tissue interstitial compartment. The probe with a diameter of 340µm increases
the interstitial volume because the interstitial width between cells can be equal
or less than 1µm. A larger interstitial volume lengthens the diffusional path
between neighbouring cells and surrounding capillaries, and needs more time
for mass transfer to equilibrate in it self. The fluid volume near the probe may
be changed as well through blood shedding, colloidal attraction of the dialysis
fluid and the evacuation of the fluid for measurements. Probe implantation may
further decrease local diffusion by fibrin deposits from bleeding and exudation
due to introduction damage by the needle, later mechanical friction, and vessel
response to environmental changes.
In the present study we placed the probe in the subcutaneous loose connective
tissue instead of the usual placement in the adipose tissue, trying to diminish
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blood shed and cell debris from the introductory needle and probe-tissue
friction. Also, the interstitium is larger in loose connective tissue than in
adipose tissue and has a better diffusional capacity(17). The steady state glucose
concentration levels in this study are kinetically much closer to the blood
plasma levels and less variable as compared to previous research performed in
adipose tissue(12). We interpret this favourable difference as resulting from the
difference in tissue anatomy and its effect on probe implantation and
functioning.
An attempt to inverse the presented model for glucose sensor calibration
purposes will encounter two difficulties. The first difficulty is the
interindividual variability of the parameters modelled, the second, the absence
of any moment of steady state in diabetes patients. The necessity to know the
insulin levels as input for the algorithm need not be a hindrance, as the insulin
administration would be remembered by a future artificial pancreas. However,
additional research is needed to construct a simple, generally applicable
algorithm to predict blood plasma glucose from subcutaneous glucose
measurements. The range of uncertainty of the blood plasma concentration may
still be indicated by the range of the model parameters. This range may be
useful e.g. to set the threshold for a hypoglycaemia alarm of a subcutaneous
sensor. So, more work has to be done on the development of the glucose sensor
and the proposed model.
The model parameters are likely to be different in diabetes patients groups from
the healthy volunteers studied here. In patients with insulin resistance or
microvascular complications, differences in tissue insulin sensitivity and
capillary permeability are difficult to study with current techniques(3). Such
studies may be improved with the here presented direct interstitial
measurements and the proposed model. The for each patient individually
assessed parameters may be of diagnostic value, and the presented model may
be validated for this purpose in future studies.
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